222 related articles for article (PubMed ID: 8326001)
41. Molecular cloning, characterization, and expression of the M antigen of Histoplasma capsulatum.
Zancopé-Oliveira RM; Reiss E; Lott TJ; Mayer LW; Deepe GS
Infect Immun; 1999 Apr; 67(4):1947-53. PubMed ID: 10085041
[TBL] [Abstract][Full Text] [Related]
42. Comparison of seven Blastomyces dermatitidis antigens for the detection of antibodies in humans with occupationally acquired blastomycosis.
Roomiany PL; Axtell RC; Scalarone GM
Mycoses; 2002 Oct; 45(8):282-6. PubMed ID: 12572716
[TBL] [Abstract][Full Text] [Related]
43. Characterization of two novel cryptococcal mannoproteins recognized by immune sera.
Biondo C; Messina L; Bombaci M; Mancuso G; Midiri A; Beninati C; Cusumano V; Gerace E; Papasergi S; Teti G
Infect Immun; 2005 Nov; 73(11):7348-55. PubMed ID: 16239533
[TBL] [Abstract][Full Text] [Related]
44. Mutation of the WI-1 gene yields an attenuated blastomyces dermatitidis strain that induces host resistance.
Wüthrich M; Filutowicz HI; Klein BS
J Clin Invest; 2000 Dec; 106(11):1381-9. PubMed ID: 11104791
[TBL] [Abstract][Full Text] [Related]
45. African strains of Blastomyces dermatitidis that do not express surface adhesin WI-1.
Klein BS; Aizenstein BD; Hogan LH
Infect Immun; 1997 Apr; 65(4):1505-9. PubMed ID: 9119493
[TBL] [Abstract][Full Text] [Related]
46. V beta1+ J beta1.1+/V alpha2+ J alpha49+ CD4+ T cells mediate resistance against infection with Blastomyces dermatitidis.
Wüthrich M; Filutowicz HI; Allen HL; Deepe GS; Klein BS
Infect Immun; 2007 Jan; 75(1):193-200. PubMed ID: 17030569
[TBL] [Abstract][Full Text] [Related]
47. Detection of antibodies and delayed dermal hypersensitivity with different lots of Blastomyces dermatitidis yeast lysate antigen: stability and specificity evaluations.
Wakamoto A; Fryer BM; Fisher MA; Johnson TJ; Lundgren DK; Knickerbocker JD; Rounds SL; Scalarone GM
Mycoses; 1997 Nov; 40(7-8):303-8. PubMed ID: 9476514
[TBL] [Abstract][Full Text] [Related]
48. Blastomyces dermatitidis antigen detection in urine specimens from dogs with blastomycosis using a competitive binding inhibition ELISA.
Shurley JF; Legendre AM; Scalarone GM
Mycopathologia; 2005 Sep; 160(2):137-42. PubMed ID: 16170609
[TBL] [Abstract][Full Text] [Related]
49. Schistosoma mansoni: comparison of cloned tropomyosin antigens shared between adult parasites and Biomphalaria glabrata.
Weston DS; Kemp WM
Exp Parasitol; 1993 Jun; 76(4):358-70. PubMed ID: 7685709
[TBL] [Abstract][Full Text] [Related]
50. Enzyme immunoassay detection of antibodies in North American blastomycosis: comparison of three Blastomyces dermatitidis antigens.
Wheeler JW; Owens RD; Scalarone GM
Mycoses; 1988 Sep; 31(9):459-65. PubMed ID: 3200261
[No Abstract] [Full Text] [Related]
51. Transforming DNA integrates at multiple sites in the dimorphic fungal pathogen Blastomyces dermatitidis.
Hogan LH; Klein BS
Gene; 1997 Feb; 186(2):219-26. PubMed ID: 9074500
[TBL] [Abstract][Full Text] [Related]
52. Comparison of the enzyme immunoassay, immunodiffusion, and complement fixation tests in detecting antibody in human serum to the A antigen of Blastomyces dermatitidis.
Klein BS; Kuritsky JN; Chappell WA; Kaufman L; Green J; Davies SF; Williams JE; Sarosi GA
Am Rev Respir Dis; 1986 Jan; 133(1):144-8. PubMed ID: 3079974
[TBL] [Abstract][Full Text] [Related]
53. Serologic response in blastomycosis: diagnostic value of double immunodiffusion assay.
Williams JE; Murphy R; Standard PG; Phair JP
Am Rev Respir Dis; 1981 Feb; 123(2):209-12. PubMed ID: 6786147
[TBL] [Abstract][Full Text] [Related]
54. Cloning and sequencing of cDNA encoding for a novel human testis-specific contraceptive vaccinogen: role in immunocontraception.
Naz RK; Zhu X; Kadam AL
Mol Reprod Dev; 2001 Sep; 60(1):116-27. PubMed ID: 11550275
[TBL] [Abstract][Full Text] [Related]
55. Interleukin 12 as an adjuvant to WI-1 adhesin immunization augments delayed-type hypersensitivity, shifts the subclass distribution of immunoglobulin G antibodies, and enhances protective immunity to Blastomyces dermatitidis infection.
Wüthrich M; Finkel-Jiminez BE; Klein BS
Infect Immun; 2000 Dec; 68(12):7172-4. PubMed ID: 11083850
[TBL] [Abstract][Full Text] [Related]
56. Preparation of reference antisera for laboratory diagnosis of blastomycosis.
Green JH; Harrell WK; Johnson JE; Benson R
J Clin Microbiol; 1979 Jul; 10(1):1-7. PubMed ID: 115894
[TBL] [Abstract][Full Text] [Related]
57. Targeted gene disruption reveals an adhesin indispensable for pathogenicity of Blastomyces dermatitidis.
Brandhorst TT; Wüthrich M; Warner T; Klein B
J Exp Med; 1999 Apr; 189(8):1207-16. PubMed ID: 10209038
[TBL] [Abstract][Full Text] [Related]
58. Detection of specific antibodies in human blastomycosis by enzyme immunoassay.
Bradsher RW; Pappas PG
South Med J; 1995 Dec; 88(12):1256-9. PubMed ID: 7502120
[TBL] [Abstract][Full Text] [Related]
59. A C-terminal EGF-like domain governs BAD1 localization to the yeast surface and fungal adherence to phagocytes, but is dispensable in immune modulation and pathogenicity of Blastomyces dermatitidis.
Brandhorst T; Wüthrich M; Finkel-Jimenez B; Klein B
Mol Microbiol; 2003 Apr; 48(1):53-65. PubMed ID: 12657044
[TBL] [Abstract][Full Text] [Related]
60. Comparative stability, sensitivity and specificity studies with different lots of Blastomyces dermatitidis yeast and mycelial lysate antigens.
Orr ML; Bono JL; Abuodeh RO; Williams SJ; Legendre AM; Scalarone GM
Mycoses; 1994; 37(5-6):155-60. PubMed ID: 7898510
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
